Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Wakenhut

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar templatePaul V Fish, Florian Wakenhut, Thomas Ryckmans, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2008
[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitorsPaul V Fish, Thomas Ryckmans, Alan Stobie, et al.
Drug Discovery Today|July 30, 2009
Understanding CYP2D6 interactionsMarcel J de Groot, Florian Wakenhut, Gavin Whitlock, et al.
The Journal of Organic Chemistry|October 4, 2012
Palladium-catalyzed synthesis of benzimidazoles and quinazolinones from common precursorsJessie E R Sadig, Radleigh Foster, Florian Wakenhut, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2008
Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuityGavin A Whitlock, Paul V Fish, M Jonathan Fray, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitorsPaul V Fish, M Jonathan Fray, Alan Stobie, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2006
Structure-activity relationships of N-substituted piperazine amine reuptake inhibitorsM Jonathan Fray, Gerwyn Bish, Paul V Fish, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2009
4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationshipsPaul V Fish, Mark D Andrews, M Jonathan Fray, et al.
Toxicology Reports|October 1, 2017
Cytoprotection by omega-3 fatty acids as a therapeutic drug vehicle when combined with nephrotoxic drugs in an intravenous emulsion: Effects on intraglomerular mesangial cellsGabriel Alejandro Bonaterra, Florian Wakenhut, Doris Röthlein, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2006
N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitorM Jonathan Fray, Gerwyn Bish, Alan D Brown, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar templatePaul V Fish, Florian Wakenhut, Thomas Ryckmans, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2008
[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitorsPaul V Fish, Thomas Ryckmans, Alan Stobie, et al.
Drug Discovery Today|July 30, 2009
Understanding CYP2D6 interactionsMarcel J de Groot, Florian Wakenhut, Gavin Whitlock, et al.
The Journal of Organic Chemistry|October 4, 2012
Palladium-catalyzed synthesis of benzimidazoles and quinazolinones from common precursorsJessie E R Sadig, Radleigh Foster, Florian Wakenhut, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2008
Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuityGavin A Whitlock, Paul V Fish, M Jonathan Fray, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitorsPaul V Fish, M Jonathan Fray, Alan Stobie, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2006
Structure-activity relationships of N-substituted piperazine amine reuptake inhibitorsM Jonathan Fray, Gerwyn Bish, Paul V Fish, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2009
4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationshipsPaul V Fish, Mark D Andrews, M Jonathan Fray, et al.
Toxicology Reports|October 1, 2017
Cytoprotection by omega-3 fatty acids as a therapeutic drug vehicle when combined with nephrotoxic drugs in an intravenous emulsion: Effects on intraglomerular mesangial cellsGabriel Alejandro Bonaterra, Florian Wakenhut, Doris Röthlein, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2006
N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitorM Jonathan Fray, Gerwyn Bish, Alan D Brown, et al.
Pageof 2